is fda stopping semaglutide Warns on Certain Forms of Compounded Compounded "semaglutide" is not FDA-approved

Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis

Mao T et al

By addressing this early trigger, the skin is less likely to move into prolonged inflammatory responses that contribute to rosacea flare-ups

Wound healing and scar treatment Scar treatment and wound healing benefit from more frequent application

Healthcare providers are encouraged to educate patients about these risks and guide them toward safe, approved options

The company says the launch strengthens its push to expand access to advanced therapies for chronic metabolic diseases, including type 2 diabetes